Mondrian Investment Partners LTD Purchases 9,833 Shares of iShares Global Healthcare ETF $IXJ

Mondrian Investment Partners LTD acquired a new stake in iShares Global Healthcare ETF (NYSEARCA:IXJ) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 9,833 shares of the company’s stock, valued at approximately $1,047,000.

Several other hedge funds have also added to or reduced their stakes in IXJ. RMG Wealth Management LLC acquired a new stake in iShares Global Healthcare ETF during the 1st quarter worth $47,000. NFSG Corp grew its stake in iShares Global Healthcare ETF by 280.5% in the third quarter. NFSG Corp now owns 723 shares of the company’s stock valued at $74,000 after acquiring an additional 533 shares during the period. Allworth Financial LP grew its stake in iShares Global Healthcare ETF by 9.9% in the second quarter. Allworth Financial LP now owns 1,674 shares of the company’s stock valued at $165,000 after acquiring an additional 151 shares during the period. World Investment Advisors acquired a new position in iShares Global Healthcare ETF in the fourth quarter valued at about $200,000. Finally, Waverly Advisors LLC bought a new stake in shares of iShares Global Healthcare ETF in the first quarter worth about $201,000.

iShares Global Healthcare ETF Price Performance

Shares of iShares Global Healthcare ETF stock opened at $109.40 on Friday. The company has a market capitalization of $4.62 billion, a P/E ratio of 21.58 and a beta of 0.55. The business has a 50-day moving average of $104.25 and a two-hundred day moving average of $99.15. iShares Global Healthcare ETF has a 1 year low of $90.28 and a 1 year high of $110.78.

iShares Global Healthcare ETF Profile

iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.